Clinical trial
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for…
NCT00074152 · ETOP IBCSG Partners Foundation, Other · Completed
Key facts
| NCT number | NCT00074152 |
|---|---|
| Title | Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer |
| Official title | A Randomized Clinical Trial Of Adjuvant Chemotherapy For Radically Resected Loco-Regional Relapse Of Breast Cancer |
| Acronym | CALOR |
| Lead sponsor | ETOP IBCSG Partners Foundation, Other |
| Collaborators | NSABP Foundation Inc |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Radiation |
| Interventions | chemotherapy, radiation therapy |
| Enrollment | 162 |
| Start date | Jul 1, 2002 |
| Primary completion | Feb 1, 2014 |
| Completion | Aug 22, 2016 |
| First posted | Dec 11, 2003 |
| Last update posted | Jun 16, 2017 |
| Countries | Australia, Belgium, Canada, Hungary, Netherlands, Peru, South Africa, Spain, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: